The horizon of the vaccine that allows us to combat the epizootic hemorrhagic disease will not foreseeably arrive before 2025. Despite the efforts to try to accelerate the process as much as possible, the deadlines of the four mandatory trials in the generation of any effective vaccine do not allow for that could hit the market before the end of the year.
This has been highlighted by the INIA-CSIC Animal Health Research Center (CISA) to the livestock farmers of the province. Although there are already vaccines to combat this disease in countries such as the United States or Japan, these are intended to combat another serotype different from the one that has emerged in Spain, which is type 8, from North Africa and about which much was unknown. your behavior.
On January 18, the Ministry of Agriculture, Fisheries and Food sent a technical report requesting national authorization through the emergency procedure to shorten the general authorization periods for the vaccine. Despite this, livestock farmers are already facing the reality of an upcoming, close and worrying campaign with the return of the heat without the long-awaited immunological preparation.
“The biggest concern is connecting campaigns. February and spring are here and it is assumed that many will be immunized, but it is not known for sure.” A concern that is added to the communication of the affected cases, essential when determining the total impact. “It is very important that people continue to register them today, even in those who have made the disease chronic despite having survived.”
Today there are several laboratories that are already working on the development of doses after the supply of material. Among them is the group of the Animal Health Research Center of the National Institute of Agricultural and Food Research and Technology, belonging to the State Agency of the Higher Council of Scientific Research (CISA-INIA-CSIC), focused on the study of recombinant vaccines that offer greater effectiveness compared to conventional ones.
Read more
2024-02-01 11:50:42
#EHE #vaccine #arrive